Targeting cardiovascular and metabolic disorders through annual nationwide screening and lifestyle intervention: insights from a cohort of 5 819 041 subjects with a 4-year follow-up

Eur J Prev Cardiol. 2023 Mar 1;30(4):329-330. doi: 10.1093/eurjpc/zwac302.

Gaetano Santulli^{1

2}, Stanislovas S Jankauskas^{1

2}, Fahimeh Varzideh^{1

2}, Pasquale Mone^{1

2}, Urna Kansakar^{1

2}

¹ Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, NY 10461, USA.
² Department of Molecular Pharmacology, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Institute for Neuroimmunology and Inflammation (INI), Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, NY 10461, USA.

No abstract available

Publication types